Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

Lilly’s Trulicity scores CV reduction indication in the US

Eli Lilly new HQApproved for risk reduction in primary and secondary populations

From: Healthcare

As new coronavirus outbreaks emerge, fears of a global pandemic escalate

Covid-19Increased quarantine measures are reported across the globe

From: Regulatory

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS buildingApproval in Japan comes before US okay

From: Regulatory

Esperion gets FDA thumbs up for cholesterol drug Nexletol

EsperionBig comeback after previous trial fail


Pharmaceutical Market Europe - February 2020

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

Ex-BMS exec jumps to Gilead to lead research group

Gilead appoints Michael Quigley to lead research team

Mike Quigley

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Digital divergence

Combining digital and pharma is proving less easy than previously thought

darwins medicine